A structural protein best known for building the internal scaffolding of cells may double as a natural defense against the ...

Microbial threats against human health are only growing. Luckily, researchers are developing new vaccines that are up to the ...

Why do diabetic wounds refuse to heal? A new scientific review highlights how disruptions in the timing and behavior of ...

CD123 is universally and highly expressed on BPDCN cells. Because CD123 expression is significantly lower on normal hematopoietic stem cells, it provides a distinct "therapeutic window," allowing for ...

The current research frontier in blastic plasmacytoid dendritic cell neoplasm (BPDCN) is moving toward combination triplet ...

Sepsis remains a major challenge in modern medicine, claiming millions of lives each year. For decades, clinical management ...

Low stress hormones in infancy may drive eczema risk by allowing immune cells to overreact to common allergens.

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Monash University in Australia have demonstrated that an intranasal vaccine booster may confer ...

Overview of secondary liver cancer care pathways, key treatment steps, and the situations where dendritic cell treatment may be discussed as a selected option.

Chronic diabetic ulcers represent one of the most challenging complications in modern healthcare, affecting over 131 million people worldwide and generating approximately $755 billion in annual ...

As Head of the Clinical Advisory Board, Prof. Eggermont will guide Tidewave’s clinical roadmap, trial design strategy, and translational positioning across solid tumor indications.

This insight explores the $1.1B primary cell market, highlighting how leaders like Lonza, Thermo Fisher, Cloud-Clone, ...